Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP746873.RAb79EYMVrIbtAraPe1ynSRl3a3RRjlysnpk31n4AG_VI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP746873.RAb79EYMVrIbtAraPe1ynSRl3a3RRjlysnpk31n4AG_VI130_assertion type Assertion NP746873.RAb79EYMVrIbtAraPe1ynSRl3a3RRjlysnpk31n4AG_VI130_head.
- NP746873.RAb79EYMVrIbtAraPe1ynSRl3a3RRjlysnpk31n4AG_VI130_assertion description "[In this study we examined the effects of VEGF GT on patients having received VEGF-A gene transfer for the treatment of symptomatic (that is, claudication or critical lower limb ischemia) peripheral arterial occlusive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP746873.RAb79EYMVrIbtAraPe1ynSRl3a3RRjlysnpk31n4AG_VI130_provenance.
- NP746873.RAb79EYMVrIbtAraPe1ynSRl3a3RRjlysnpk31n4AG_VI130_assertion evidence source_evidence_literature NP746873.RAb79EYMVrIbtAraPe1ynSRl3a3RRjlysnpk31n4AG_VI130_provenance.
- NP746873.RAb79EYMVrIbtAraPe1ynSRl3a3RRjlysnpk31n4AG_VI130_assertion SIO_000772 21776026 NP746873.RAb79EYMVrIbtAraPe1ynSRl3a3RRjlysnpk31n4AG_VI130_provenance.
- NP746873.RAb79EYMVrIbtAraPe1ynSRl3a3RRjlysnpk31n4AG_VI130_assertion wasDerivedFrom befree-20140225 NP746873.RAb79EYMVrIbtAraPe1ynSRl3a3RRjlysnpk31n4AG_VI130_provenance.
- NP746873.RAb79EYMVrIbtAraPe1ynSRl3a3RRjlysnpk31n4AG_VI130_assertion wasGeneratedBy ECO_0000203 NP746873.RAb79EYMVrIbtAraPe1ynSRl3a3RRjlysnpk31n4AG_VI130_provenance.